Ladostigil prevents gliosis, oxidative-nitrative stress and memory deficits induced by intracerebroventricular injection of streptozotocin in rats

Neuropharmacology

Volumn 52, Issue 3, 2007, Pages 836-843

  Shoham, Shai ^a   Bejar, Corina ^b   Kovalev, Eugenia ^a   Schorer Apelbaum, Donna ^b   Weinstock, Marta ^b  

^a HERZOG HOSPITAL   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Astrocytes; Memory deficits; Microglia; Neuroprotection; Oxidative nitrative stress

Indexed keywords

3 NITROTYROSINE; CHOLINESTERASE INHIBITOR; GLUCOSE; LADOSTIGIL; MONOAMINE OXIDASE INHIBITOR; STREPTOZOCIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CORPUS CALLOSUM; DISEASE MODEL; DRUG EFFECT; DRUG MECHANISM; EPISODIC MEMORY; GLIA CELL; GLIOSIS; HIPPOCAMPUS; IMAGE ANALYSIS; IMMUNOREACTIVITY; MALE; MICROGLIA; NEUROPROTECTION; NITRATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SPATIAL MEMORY; SPRAGUE DAWLEY RAT;

ANIMALS; BEHAVIOR, ANIMAL; CELL COUNT; CHOLINE O-ACETYLTRANSFERASE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; IMMUNOHISTOCHEMISTRY; INDANS; INJECTIONS, INTRAVENTRICULAR; MALE; MEMORY DISORDERS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN; TYROSINE; VESICULAR ACETYLCHOLINE TRANSPORT PROTEINS;

EID: 33846924328     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.10.005     Document Type: Article

References (36)

1. Arnaiz E., Jelic V., Almkvist O., Wahlund L.O., Winblad B., Valind S., and Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 12 (2001) 851-855
2. Bartolini L., Casamenti F., and Pepeu G. Aniracetam restores object recognition impaired by age, scopolamine, and nucleus basalis lesions. Pharmacol. Biochem. Behav. 53 (1996) 277-283
3. Bolanos J.P., Cidad P., Garcia-Nogales P., Delgado-Esteban M., Fernandez E., and Almeida A. Regulation of glucose metabolism by nitrosative stress in neural cells. Mol. Asp. Med. 25 (2004) 61-73
4. Craft J.M., Watterson D.M., Frautschy S.A., and Van Eldik L.J. Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo. Neurobiol. Aging 25 (2004) 1283-1292
5. Duelli R., Schrock H., Kuschinsky W., and Hoyer S. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int. J. Dev. Neurosci. 12 (1994) 737-743
6. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
7. Finch C.E. Neurons, glia, and plasticity in normal brain aging. Neurobiol. Aging 24 Suppl. 1 (2003) S123-S127 (discussion S131)
8. Huang W., Chen Y., Shohami E., and Weinstock M. Neuroprotective effect of rasagiline, a selective monoamine oxidase-B inhibitor, against closed head injury in the mouse. Eur. J. Pharmacol. 366 (1999) 127-135
9. Katzman R. Alzheimer's disease. N. Engl. J. Med. 314 (1986) 964-973
10. Lannert H., and Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci. 112 (1998) 1199-1208
11. Lipton S.A., and Rosenberg P.A. Excitatory amino acids as a final common pathway for neurologic disorders. N. Engl. J. Med. 330 (1994) 613-622
12. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 304 (2003) 1-7
13. Maruyama W., Weinstock M., Youdim M.B., Nagai M., and Naoi M. Anti-apoptotic action of anti-Alzheimer drug, TV3326 [(N-propargyl)-(3R)-aminoindan-5-yl]-ethyl methyl carbamate, a novel cholinesterase-monoamine oxidase inhibitor. Neurosci. Lett. 341 (2003) 233-236
14. Mayer G., Nitsch R., and Hoyer S. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res. 532 (1990) 95-100
15. McCarty M.F. Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. Med. Hypotheses 67 (2006) 251-269
16. McGeer E.G., and McGeer P.L. Inflammatory processes in Alzheimer's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 741-749
17. Miguel-Hidalgo J.J., Alvarez X.A., Cacabelos R., and Quack G. Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res. 958 (2002) 210-221
18. Morgan T.E., Xie Z., Goldsmith S., Yoshida T., Lanzrein A.S., Stone D., Rozovsky I., Perry G., Smith M.A., and Finch C.E. The mosaic of brain glial hyperactivity during normal ageing and its attenuation by food restriction. Neuroscience 89 (1999) 687-699
19. Mrak R.E., and Griffin W.S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging 26 (2005) 349-354
20. Mumby D.G., Gaskin S., Glenn M.J., Schramek T.E., and Lehmann H. Hippocampal damage and exploratory preferences in rats: memory for objects, places, and contexts. Learn Mem. 9 (2002) 49-57
21. Nichols N.R., Day J.R., Laping N.J., Johnson S.A., and Finch C.E. GFAP mRNA increases with age in rat and human brain. Neurobiol. Aging 14 (1993) 421-429
22. Olanow C.W. Rationale for considering that propargylamines might be neuroprotective in Parkinson's disease. Neurology 66 (2006) S69-S79
23. Prickaerts J., Fahrig T., and Blokland A. Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav. Brain Res. 102 (1999) 73-88
24. Sharma M., and Gupta Y.K. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol. Biochem. Behav. 70 (2001) 325-331
25. Sharma M., and Gupta Y.K. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 71 (2002) 2489-2498
26. Shoham S., Bejar C., Kovalev E., and Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp. Neurol. 184 (2003) 1043-1052
27. Strohmeyer R., and Rogers J. Molecular and cellular mediators of Alzheimer's disease inflammation. J. Alzheimers Dis. 3 (2001) 131-157
28. 2 as mediator for DNA fragmentation. Diabetes 40 (1991) 1141-1145
29. Tuppo E.E., and Arias H.R. The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37 (2005) 289-305
30. Wang R.H., Bejar C., and Weinstock M. Gender differences in the effect of rivastigmine on brain cholinesterase activity and cognitive function in rats. Neuropharmacology 39 (2000) 497-506
31. Weinstock M., Bejar C., and Shoham S. Ladostigil attenuates gliosis and prevents oxidative-nitrative stress in hippocampus and memory deficits induced in rats by intracerebroventricular injection of streptozotocin. Rev. Neurosci. 16 Suppl. 1 (2005) S67 (Abstract)
32. Weinstock M., Bejar C., Wang R.H., Poltyrev T., Gross A., Finberg J.P., and Youdim M.B. TV3326, a novel neuroprotective drug with cholinesterase and monoamine oxidase inhibitory activities for the treatment of Alzheimer's disease. J. Neural. Transm. Suppl. (2000) 157-169
33. Weinstock M., Gorodetsky E., Poltyrev T., Gross A., Sagi Y., and Youdim M. A novel cholinesterase and brain-selective monoamine oxidase inhibitor for the treatment of dementia comorbid with depression and Parkinson's disease. Prog. Neuropsychopharmacol. Biol. Psychiatry 27 (2003) 555-561
34. Weinstock M., Gorodetsky E., Wang R.H., Gross A., Weinreb O., and Youdim M.B. Limited potentiation of blood pressure response to oral tyramine by brain-selective monoamine oxidase A-B inhibitor, TV-3326 in conscious rabbits. Neuropharmacology 43 (2002) 999-1005
35. Winters B.D., Forwood S.E., Cowell R.A., Saksida L.M., and Bussey T.J. Double dissociation between the effects of peri-postrhinal cortex and hippocampal lesions on tests of object recognition and spatial memory: heterogeneity of function within the temporal lobe. J. Neurosci. 24 (2004) 5901-5908
36. Youdim M.B., and Weinstock M. Molecular basis of neuroprotective activities of rasagiline and the anti-Alzheimer drug TV3326 [(N-propargyl-(3R)aminoindan-5-YL)-ethyl methyl carbamate]. Cell. Mol. Neurobiol. 21 (2001) 555-573